secwatch.observer — SEC 8-K summary
======================================

Issuer:     Edwards Lifesciences Corp (EW)
CIK:        0001099800
Form:       8-K
Filed at:   2025-07-25T23:59:59+00:00
Accession:  0001193125-25-164527
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Edwards Lifesciences EVP Larry Wood to resign; Daniel Lippis to lead TAVR business
--------------------------------------------------------------------------------

- Larry Wood, Corporate VP and Group President of TAVR and Surgical Structural Heart, resigns effective Sept 1, 2025.
- Wood departs to accept a senior leadership role at another company outside cardiovascular.
- Daniel J. Lippis, current Corporate VP for Japan, Greater China, and Asia Pacific, will succeed as Corporate VP for TAVR.
- The transition is effective September 1, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1099800/000119312525164527/0001193125-25-164527-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1099800/000119312525164527/d66195d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-164527

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer